Log In
BCIQ
Print this Print this
 

QBECP SSI

  Manage Alerts
Collapse Summary General Information
Company Qu Biologics Inc.
DescriptionSite-specific immunomodulator (SSI) containing components of inactivated urogenic Escherichia coli to stimulate the innate immune system
Molecular Target
Mechanism of ActionImmune modulation
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today